Aesthetic Medicine Global Market Report 2024

The aesthetic medicine market size has grown strongly in recent years. It will grow from $62.37 billion in 2023 to $68.57 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The historical growth in aesthetic medicine owes to rising disposable income and urbanization, an increasing obese population, and the popularity surge of noninvasive and minimally invasive aesthetic procedures.

The aesthetic medicine market size is expected to see strong growth in the next few years. It will grow to $96.66 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The forecasted growth in aesthetic medicine is propelled by a growing elderly population, rapid urbanization, increased disposable income, and a rise in mergers and acquisitions. Major trends include product innovations, artificial intelligence integration in aesthetics, focal radio frequency technology development, laser-assisted liposuction utilization, and emphasis on partnerships and collaborations.

The aesthetic medicine market is poised for growth due to the escalating global obese population. Unhealthy dietary habits, sedentary lifestyles, and influences during parental and postnatal stages are contributing to the widespread prevalence of obesity. Individuals grappling with obesity increasingly turn to aesthetic medicine for procedures such as fat reduction, meso/face-lift, and other benefits, encompassing both invasive and non-invasive approaches. For instance, a European health interview survey conducted by Eurostat, the statistical office of the European Union, in July 2021 revealed that 52.7% of the adult population in Europe was overweight. This data underscores the substantial market potential driven by the expanding obese population globally.

The aesthetic medicine market is further fueled by rapid urbanization and an increase in disposable income, creating a conducive environment for growth. The upsurge in disposable income amplifies consumers' spending on personal care, and the affordability of premium products fuels the demand for aesthetic medicine. Moreover, the urban population, characterized by heightened awareness of personal appearance, contributes significantly to the market's growth. According to projections by the United Nations, it is anticipated that by 2050, approximately 68% of the world's total population will reside in urban areas, a notable increase from the current 55%. Additionally, data from Fitch Solutions indicates that personal care and effects spending is forecasted to reach IDR3,802 billion ($45.3 billion) in 2026, reflecting an average annual increase of 11.8% from IDR2,527.5 billion ($33.3 billion) in 2022. This underscores the role of rapid urbanization and rising disposable income as key drivers propelling the growth of the aesthetic medicine market.

Companies operating in the aesthetic medicine market are actively engaged in product innovations as part of their strategy to fortify their market position. A notable example is Lumenis, an Israel-based energy-based medical device company, which, in January 2022, introduced the Splendor X device to the UK market. This innovative device is powered by BLEND X technology, incorporating a binary laser emission of Nd: YAG (neodymium-doped yttrium aluminum garnet; Nd: Y3Al5O12) (1064 nm) and Alexandrite (755 nm) wavelengths with synchronized and adjustable proportions. Designed for both men and women, it is versatile, treating various body areas such as the face, bikini line, legs, arms, stomach, and underarms, and is suitable for all Fitzpatrick skin types.

The integration of Artificial Intelligence (AI) in aesthetics is a noteworthy trend gaining traction in the aesthetic medicine market. AI plays a pivotal role in assisting specialists, enabling them to deliver optimal aesthetic treatments to patients. A case in point is BeautyFix, a US-based company specializing in cosmetics, which, in October 2022, launched Aesthetics Simulation technology. This technology, accessible on any device or web browser, offers a high-tech patient experience, allowing potential clients to simulate their aesthetic results. Developed by EntityMed, an Israel-based digital health company, this Aesthetics Simulation software is the first clinical-grade, tech-enabled AI simulator for injectables available in the U.S. market, having undergone testing on over 10,000 patients.

In December 2021, Allergan Aesthetics, a subsidiary of AbbVie, completed the acquisition of Soliton, Inc., a US-based medical devices company, for $550 million. This acquisition provided Allergan access to Soliton's RESONIC rapid acoustic pulse (RAP) technology, specifically designed for non-invasive cellulite improvement. Presently, the device is approved in the US solely for cellulite and tattoo removal. With the addition of Soliton and its technology, Allergan Aesthetics expanded its non-invasive body contouring treatment portfolio to include an effective method for reducing cellulite appearance. Soliton, Inc. specializes in manufacturing aesthetic-focused medical devices for tattoo removal and cellulite treatment.

Major companies operating in the aesthetic medicine market report are AbbVie, Johnson & Johnson, Galderma, Bausch Health, Shanghai Fosun Pharmaceutical Co, Cynosure, El.En. S.p.A, Cutera, Merz Pharma, Syneron Candela, Vive Cosmetics, VLCC Personal Care, Kazima Cosmetics Mitsubishi Heavy Industries, Ltd., SoftFil, Sinclair Phama, BIOXIS pharmaceuticals, Premium Aesthetics LLC, Martinex, Medical Esthetic, Ipsen Pharma, Ruby Surgery & Aesthetics, Medicina Estética Regenerativa, Xcite Technologies, ReNue aesthetic medicine, VYDENCE Medical, Julphar, MSD (Musculoskeletal disorders), Next Biosciences, Novartis South Africa, BBI Solutions, Aspen Pharmacare, 54gene, Altis Biologics, Cipla Medpro, Sanofi Genzyme.

North America was the largest region in the aesthetic medicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aesthetic medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aesthetic medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Primary products in aesthetic medicine consist of facial aesthetic items, body contouring devices, cosmetic implants, hair removal tools, and skin aesthetic devices. Facial aesthetics involve non-surgical procedures such as botox, fillers, and anti-wrinkle injections tailored for facial enhancement. These procedures, invasive and non-invasive, are performed in various settings such as clinics, hospitals, medical spas, beauty centers, and even at-home care environments.

The aesthetic medicine market research report is one of a series of new reports that provides aesthetic medicine market statistics, including the aesthetic medicine industry global market size, regional shares, competitors with an aesthetic medicine market share, detailed aesthetic medicine market segments, market trends and opportunities, and any further data you may need to thrive in the aesthetic medicine industry. This aesthetic medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aesthetic medicine market consists of sales of chemical peels, cosmetic dermatology treatments, dermal fillers, and hair transplants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.